Cerner Corporation (CERN)

Check out top investors' recommendation for CERN
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers worldwide. It offers the Cerner Millennium architecture, which combines clinical, financial, and management information systems that allows providers to access an individual’s electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front and back-office professionals, and consumers. The company also provides the Healthe Intent platform, a cloud-based architectural platform for population health that is agnostic to the source EHR and captures research, evidence, and financial and operational data, as well as provides the ability to apply statistical algorithms against contextual clinical activity to recommend clinical action. In addition, it offers a range of services, including implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, healthcare data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third party administrator services for employer-based health plans. The company serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
John Difucci JPMorgan Buy   Oct 13, '17     79.00  Oct 13, '18  N/A 
Sean Wieland Piper Jaffray Buy   Oct 12, '17     77.00  Oct 12, '18  N/A 
Steven Halper Lazard Capital Markets Buy   Oct 10, '17     77.00  Oct 10, '18  N/A 
Richard Close Avondale Partners LLC Buy   Oct 06, '17     69.00  Oct 06, '18  N/A 
Donald Hooker Morgan Stanley Buy   Sep 20, '17     76.00  Sep 20, '18  N/A 
Jamie Stockton Wells Fargo Securities, Llc Buy   Sep 07, '17       Sep 07, '18  N/A 
John Difucci JPMorgan Buy   Aug 11, '17     74.00  Aug 11, '18  N/A 
Sean Wieland Piper Jaffray Buy   Jul 28, '17     70.00  Jul 28, '18  N/A 
Richard Close Avondale Partners LLC Buy   Jul 21, '17     66.00  Jul 21, '18  N/A 
Steven Halper Lazard Capital Markets Buy   Jul 09, '17     77.00  Jul 09, '18  N/A 
Steven Halper Lazard Capital Markets Buy   Feb 22, '17     66.00  Feb 22, '18  N/A 
Richard Close Avondale Partners LLC Buy   Jan 13, '17     63.00  Jan 13, '18  N/A 
Donald Hooker Morgan Stanley Sell   Dec 13, '16     45.00  Dec 13, '17  N/A 
David Windley Jefferies & Co. Buy   Nov 03, '16     68.00  Nov 03, '17  N/A 
George Hill Citi Buy   Nov 02, '16     58.00  Nov 02, '17  N/A 
David Larsen Leerink Swann Llc Buy   Nov 02, '16     65.00  Nov 02, '17  N/A 
Sean Wieland Piper Jaffray Buy   Aug 29, '16       Aug 29, '17  N/A 
George Hill Citi Buy   Aug 03, '16     73.00  Aug 03, '17  N/A 
Sean Wieland Piper Jaffray Buy   Feb 17, '16   52.81  70.00  Feb 17, '17  5.30% 
George Hill Citi Buy   Feb 17, '16   52.81  59.00  Feb 17, '17  11.72% 
< previous1234